Sandra Moreno

627 total citations
30 papers, 429 citations indexed

About

Sandra Moreno is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Agronomy and Crop Science. According to data from OpenAlex, Sandra Moreno has authored 30 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 17 papers in Ecology, Evolution, Behavior and Systematics and 11 papers in Agronomy and Crop Science. Recurrent topics in Sandra Moreno's work include Viral Infections and Vectors (22 papers), Vector-Borne Animal Diseases (17 papers) and Animal Disease Management and Epidemiology (11 papers). Sandra Moreno is often cited by papers focused on Viral Infections and Vectors (22 papers), Vector-Borne Animal Diseases (17 papers) and Animal Disease Management and Epidemiology (11 papers). Sandra Moreno collaborates with scholars based in Spain, United States and United Kingdom. Sandra Moreno's co-authors include Alejandro Brun, Javier Ortego, Eva Calvo-Pinilla, Alejandro Marín-López, Belén Borrego, Aitor Nogales, Sergio Utrilla-Trigo, Gema Lorenzo, Nina Bogdanchikova and Horacio Almanza‐Reyes and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Sandra Moreno

26 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Moreno Spain 13 256 157 98 54 48 30 429
Elena López-Gil Spain 9 209 0.8× 124 0.8× 43 0.4× 20 0.4× 26 0.5× 9 307
Hongling Wen China 13 355 1.4× 147 0.9× 32 0.3× 32 0.6× 162 3.4× 46 628
Hu Dong China 14 113 0.4× 67 0.4× 153 1.6× 91 1.7× 174 3.6× 43 502
Peiyang Ding China 12 152 0.6× 67 0.4× 101 1.0× 43 0.8× 170 3.5× 39 382
Yujiao Zhang China 11 295 1.2× 28 0.2× 77 0.8× 52 1.0× 45 0.9× 32 472
Ryosuke Matsuura Japan 10 53 0.2× 49 0.3× 53 0.5× 73 1.4× 35 0.7× 24 282
Katherine L. Marshall United States 12 123 0.5× 38 0.2× 77 0.8× 44 0.8× 169 3.5× 31 503
Pooneh Rahimi Iran 10 150 0.6× 30 0.2× 39 0.4× 50 0.9× 132 2.8× 36 389
Jiewen Zhou China 7 231 0.9× 23 0.1× 56 0.6× 41 0.8× 49 1.0× 11 452

Countries citing papers authored by Sandra Moreno

Since Specialization
Citations

This map shows the geographic impact of Sandra Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Moreno more than expected).

Fields of papers citing papers by Sandra Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Moreno. The network helps show where Sandra Moreno may publish in the future.

Co-authorship network of co-authors of Sandra Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Moreno. A scholar is included among the top collaborators of Sandra Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Moreno. Sandra Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calvo-Pinilla, Eva, Sandra Moreno, Rafael Blasco, et al.. (2025). Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses. Vaccines. 13(3). 291–291. 1 indexed citations
2.
Borrego, Belén, Sandra Moreno, Eva Calvo-Pinilla, et al.. (2025). The 40Fp8 vaccine strain is safe and protects pregnant ewes from a virulent RVFV challenge. npj Vaccines. 10(1). 206–206.
3.
Moreno, Sandra, Gema Lorenzo, José I. Núñez, et al.. (2024). Safety and Efficacy upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued Virus. Viruses. 16(1). 87–87. 3 indexed citations
4.
Nogales, Aitor, Sandra Moreno, Gema Lorenzo, et al.. (2024). Novel replication-competent reporter-expressing Rift Valley fever viruses for molecular studies. Journal of Virology. 99(1). e0178224–e0178224.
5.
Utrilla-Trigo, Sergio, Eva Calvo-Pinilla, Gema Lorenzo, et al.. (2024). Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus. Frontiers in Immunology. 15. 1440407–1440407. 4 indexed citations
6.
7.
Utrilla-Trigo, Sergio, Eva Calvo-Pinilla, Alejandro Marín-López, et al.. (2022). The combined expression of the nonstructural protein NS1 and the N-terminal half of NS2 (NS21-180) by ChAdOx1 and MVA confers protection against clinical disease in sheep upon bluetongue virus challenge. DIGITAL.CSIC (Spanish National Research Council (CSIC)). 13 indexed citations
8.
Borrego, Belén, et al.. (2022). Identification of Single Amino Acid Changes in the Rift Valley Fever Virus Polymerase Core Domain Contributing to Virus Attenuation In Vivo. Frontiers in Cellular and Infection Microbiology. 12. 875539–875539. 6 indexed citations
9.
10.
Borrego, Belén, et al.. (2021). The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice. Viruses. 13(4). 542–542. 12 indexed citations
11.
Almanza‐Reyes, Horacio, Sandra Moreno, Belén Borrego, et al.. (2021). Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo. PLoS ONE. 16(8). e0256401–e0256401. 73 indexed citations
12.
Marciello, Marzia, Sandra Moreno, Rubén Hernández-Alcoceba, et al.. (2021). Broad virus inactivation using inorganic micro/nano-particulate materials. Materials Today Bio. 13. 100191–100191. 18 indexed citations
13.
López-Gil, Elena, Sandra Moreno, Javier Ortego, et al.. (2020). MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses. Vaccines. 8(1). 82–82. 12 indexed citations
14.
Calvo-Pinilla, Eva, Alejandro Marín-López, Sandra Moreno, et al.. (2020). A protective bivalent vaccine against Rift Valley fever and bluetongue. npj Vaccines. 5(1). 70–70. 28 indexed citations
15.
Moreno, Sandra, Eva Calvo-Pinilla, Stéphanie Devignot, et al.. (2020). Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge. PLoS neglected tropical diseases. 14(12). e0008942–e0008942. 12 indexed citations
16.
Utrilla-Trigo, Sergio, Eva Calvo-Pinilla, Alejandro Marín-López, et al.. (2020). Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus. Vaccines. 8(3). 346–346. 21 indexed citations
17.
Boshra, Hani, Gema Lorenzo, Sandra Moreno, et al.. (2020). A novel Schmallenberg virus subunit vaccine candidate protects IFNAR-/- mice against virulent SBV challenge. Scientific Reports. 10(1). 18725–18725. 10 indexed citations
18.
Marín-López, Alejandro, Eva Calvo-Pinilla, Sandra Moreno, et al.. (2019). Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor. Viruses. 11(1). 35–35. 27 indexed citations
19.
Marín-López, Alejandro, Roberto Bermúdez, Eva Calvo-Pinilla, et al.. (2016). Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4. International Journal of Biological Sciences. 12(12). 1448–1460. 21 indexed citations
20.
Pérez, Carlos, Sandra Moreno, Artur Summerfield, et al.. (2007). Characterisation of porcine bone marrow progenitor cells identified by the anti-c-kit (CD117) monoclonal antibody 2B8/BM. Journal of Immunological Methods. 321(1-2). 70–79. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena López-Gil Breakdown of academic impact, for papers by Hongling Wen Breakdown of academic impact, for papers by Hu Dong Breakdown of academic impact, for papers by Peiyang Ding Breakdown of academic impact, for papers by Yujiao Zhang Breakdown of academic impact, for papers by Ryosuke Matsuura Breakdown of academic impact, for papers by Katherine L. Marshall Breakdown of academic impact, for papers by Pooneh Rahimi Breakdown of academic impact, for papers by Jiewen Zhou
Rankless by CCL
2026